Assembly Biosciences
ASMB
24 hedge funds and large institutions have $33.4M invested in Assembly Biosciences in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 2 closing their positions.
267% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 3
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
137% more capital invested
Capital invested by funds: $14.1M → $33.4M (+$19.3M)
9% more funds holding
Funds holding: 22 → 24 (+2)
Top Buyers
| 1 |
QF
QVT Financial
New York
|
+$4.39M |
| 2 |
Jennison Associates
New York
|
+$4.06M |
| 3 |
VAM
Visium Asset Management
New York
|
+$3.16M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$143K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$108K |
Top Sellers
ASMB Hedge Fund Activity: Q4 2014 in Review
24 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2014, worth a combined $33.4M — up 137% from $14.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ASMB positions and 2 closed out — a net gain of 4 holders — while 11 added to existing stakes and 3 trimmed.
The largest buyer was QVT Financial, opening a new position worth an estimated $4.39M. The largest seller was BlackRock Institutional Trust, cutting an estimated $136K.
- 24 institutional investors held Assembly Biosciences (ASMB) as of Q4 2014, up from 22 in Q3 2014.
- Funds reported $33.4M of Assembly Biosciences stock for Q4 2014, up 137% quarter-over-quarter.
- 6 funds opened new Assembly Biosciences positions in Q4 2014 and 2 closed out, a net change of +4 holders.
- The largest Assembly Biosciences buyer in Q4 2014 was QVT Financial, an estimated $4.39M added.
- The largest Assembly Biosciences seller in Q4 2014 was BlackRock Institutional Trust, an estimated $136K sold.
Based on aggregated 13F filings for Q4 2014.